Name: Non-Invasive Prenatal Testing Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17405
Availability: InStock

Non-Invasive Prenatal Testing Market – Report Overview

Pacific Business Consulting’s “Non-Invasive Prenatal Testing Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Non-Invasive Prenatal Testing market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Non-Invasive Prenatal Testing market exceeded a valuation of over US$ 3.4 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 9.0% from 2023 to 2030. The market is expected to potentially surpass US$ 6.0 Billion by 2030.

The market is expected to experience growth due to the increasing demand for non-invasive prenatal testing (NIPT), heightened collaborations and licensing agreements, and improvements in reimbursement scenarios. Moreover, the rising incidence of chromosomal abnormalities is anticipated to further boost market expansion. Many manufacturing companies maintained regular communication with the U.S. FDA to stay informed about potential supply chain disruptions.

Key manufacturers are actively working to introduce advanced products into the market. They offer alternative testing options, such as tests for copy number variants, rarer trisomies, and microdeletions, including 11q deletion (Jacobsen syndrome), 22q11.2 deletions (DiGeorge syndrome), 15q deletion (Prader–Willi and Angelman syndromes), 15p deletion (cri-du-chat syndrome), and 4p deletion (Wolf–Hirschhorn syndrome. For instance, in May 2022, ARUP Laboratories launched a new cfDNA test with higher sensitivity and specificity compared to other NIPTs. The test is approved for screening pregnant women carrying a single fetus and can be performed as early as 10 weeks of pregnancy.

The NIPT market is highly saturated with existing key players, and companies are forming partnerships and collaborations to maintain a stable position. In January 2022, QIAGEN and Atila BioSystems collaborated to enhance the application portfolio of their digital PCR platform QIAcuity with NIPT solutions. Additionally, in June 2021, Illumina partnered with Next Generation Genomic to introduce a CE-IVD, NGS-based NIPT test, VeriSeq NIPT Solution v2 in Thailand, aiming to expand patient access to NIPT’s next-generation sequencing.

These entities also facilitate cross-selling of NIPTs with other procedures, including carrier screening and preimplantation screening for in vitro fertilization. To provide these services, players collaborate with entities operating in parallel markets and other laboratories to gain significant market share. For example, in August 2022, LGC Clinical Diagnostics extended its partnership with the Stanford University Department of Obstetrics and Gynecology for NIPT reference materials.

China presents a significant opportunity for noninvasive prenatal screening, with nearly 14.65 million annual births and a growing number of high-risk pregnancies. Similarly, India faces a heavy burden of genetic diseases, with chromosomal abnormalities found in 1 in 166 newborns, and trisomy 21 (Down syndrome) having a high incidence rate of 1 in 800 births, resulting in 32,000 newborns with Down syndrome annually. Accurate and early screening using NIPT can benefit families by providing information about their baby’s genetic issues.

While NIPTs have been in the market for a considerable time, the pressure for upcoming products to be affordable and accessible is continuous. This places additional pressure on research and development (R&D) efforts to create more effective and affordable products. Mature players are investing more in R&D to develop novel and precise diagnostics, focusing on delivering economic value to customers and healthcare professionals. In contrast, emerging players seek funding support from government bodies and healthcare organizations, emphasizing the development of Point-of-Care (PoC) products and strengthening the supply chain to reach a large pool of end-users.

Despite the market’s overall growth, ethical concerns arise in certain regions due to the unnatural creation and destruction of human embryos after sex determination. The application of NIPT for sex selection on non-medical grounds is prohibited, potentially restraining market growth in countries where sex-based abortions are prevalent. Addressing these issues requires additional policy guidance for clinicians to mitigate the impact of this restraint over the forecast period.

Leading players in the Non-Invasive Prenatal Testing segment, including Myriad Women’s Health, Inc., QIAGEN, Laboratory Corp. of America Holdings, Progenity, Inc., Quest Diagnostics, Inc., Genesis Genetics, Natera, Inc., Centogene N.V., Illumina, Inc., Verinata Health, Inc., Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd., are expected to play a crucial role in shaping the future landscape of Non-Invasive Prenatal Testing technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Non-Invasive Prenatal Testing market. It also delves into the analysis of present and prospective market competition within the global Non-Invasive Prenatal Testing market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Non-Invasive Prenatal Testing market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Non-Invasive Prenatal Testing market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Non-Invasive Prenatal Testing
- Global Market Outlook: Non-Invasive Prenatal Testing
Competitive Intelligence Analysis: Non-Invasive Prenatal Testing
Therapeutic Sector SWOT
Technology Roadmap Analysis: Non-Invasive Prenatal Testing
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Non-Invasive Prenatal Testing
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Non-Invasive Prenatal Testing: Ten Major Market (10MM) – Market Analysis, By Product
- Instruments
- Consumables & Reagents
Non-Invasive Prenatal Testing: Ten Major Market (10MM) – Market Analysis, By Technology
- Array Technology
- PCR
- NGS
- Others
Non-Invasive Prenatal Testing: Ten Major Market (10MM) – Market Analysis, By End User
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
Non-Invasive Prenatal Testing: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

S. Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

K. Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Germany Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

France Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Italy Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Spain Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Japan Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

China Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Australia Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

India Non-Invasive Prenatal Testing – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Product
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Product
  - By Technology
  - By End User

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Non-Invasive Prenatal Testing Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Diabetes Mellitus (DM) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Diabetic Neuropathic Pain (DNP) Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Heart Failure (HF) Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Melanoma Therapeutics Market in United States, United Kingdom– Market Outlook, Market Assessment and Market Forecast (2023-2030)

Non-Small Cell Lung Cancer (NSCLC) Market in United States, United Kingdom, Cell and Gene Therapy – Market Outlook, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch